The goal of the UNC CFAR Immunology Core is to support HIV research by UNC and affiliated investigators aimed at stemming the HIV pandemic. The Immunology Core will achieve this goal by providing infrastructure, services and leadership to facilitate studies ofthe Immunologic aspects of HIV pathogenesis, therapeutics and diagnostics. Specifically, the Core will provide services including: biospecimen procurement and distribution, flow cytometry, immune function testing, soluble marker testing, mmunogenetic testing and training/education. The Core will promote the use of these services by supporting developmental awardees, assisting with the development of grants and contracts addressing immunologic questions of HIV infection and fostering collaborations with industry for evaluation of novel technologies for the diagnosis and monitoring of HIV infection. The Core's established services as well as methods and tools developed via support of investigators and industry will also be used to support various DAIDS groups (ACTG, HPTN, CHAVI), to build capacity at international sites and to support UNC CFAR initiatives including HIV latency, primary infection and AIDS malignancies. Finally, the Core will actively seek input from these users as well as other internal and external advisors to continually assess and improve Core services. By supporting a broad research agenda including pathogenesis, therapeutics and diagnostics, the Core will be a significant component of the efforts to address the HIV pandemic.

Public Health Relevance

The Immunology Core research plan will impact public health in several ways. The core will provide infrastructure and resources to support studies aimed at: (1) preventing transmission of HIV;(2) improving the diagnosis and monitoring of infected persons;(3) elucidating mechanisms of HIV disease, and;(4) improving therapies for HIV infected persons.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-17
Application #
8708743
Study Section
Special Emphasis Panel (ZAI1-ELB-A)
Project Start
2014-08-01
Project End
2016-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
17
Fiscal Year
2014
Total Cost
$134,180
Indirect Cost
$43,389
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Buchanan, Ashley L; Hudgens, Michael G; Cole, Stephen R et al. (2018) Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights. J R Stat Soc Ser A Stat Soc 181:1193-1209
Muessig, Kathryn E; Knudtson, Kelly A; Soni, Karina et al. (2018) ""I DIDN'T TELL YOU SOONER BECAUSE I DIDN'T KNOW HOW TO HANDLE IT MYSELF."" DEVELOPING A VIRTUAL REALITY PROGRAM TO SUPPORT HIV-STATUS DISCLOSURE DECISIONS. Digit Cult Educ 10:22-48
Bradley, Todd; Ferrari, Guido; Haynes, Barton F et al. (2018) Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency. Cell Rep 25:107-117.e3
Adimora, Adaora A; Ramirez, Catalina; Benning, Lorie et al. (2018) Cohort Profile: The Women's Interagency HIV Study (WIHS). Int J Epidemiol 47:393-394i
Garrett, Katy L; Chen, Jingxian; Maas, Brian M et al. (2018) A Pharmacokinetic/Pharmacodynamic Model to Predict Effective HIV Prophylaxis Dosing Strategies for People Who Inject Drugs. J Pharmacol Exp Ther 367:245-251
Ong, Jason J; Wei, Chongyi; Pan, Stephen et al. (2018) Individuals have the right to avoid sex with partners unwilling to test for HIV but do not have a right to force them to test for HIV. J Acquir Immune Defic Syndr :
Qin, Yilu; Han, Larry; Babbitt, Andrew et al. (2018) Experiences using and organizing HIV self-testing. AIDS 32:371-381
Hightow-Weidman, Lisa B; Muessig, Kathryn; Rosenberg, Eli et al. (2018) University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development. JMIR Res Protoc 7:e10365
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Henderson, Gail E; Peay, Holly L; Kroon, Eugene et al. (2018) Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment. J Med Ethics 44:270-276

Showing the most recent 10 out of 1688 publications